Idorsia Ltd. (IDRSF)
5.65
-0.10
(-1.74%)
USD |
OTCM |
May 29, 16:00
Idorsia EPS Diluted (Quarterly) : -0.3918 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 1.970 |
| AC Immune SA | -0.1914 |
| CRISPR Therapeutics AG | -1.280 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -97.29M |
| Revenue (Quarterly) | 60.02M |
| Total Expenses (Quarterly) | 157.32M |
| Enterprise Value | 2.923B |
| Gross Profit Margin (Quarterly) | 72.02% |
| Profit Margin (Quarterly) | -162.1% |
| Earnings Yield | -12.38% |
| Normalized Earnings Yield | -9.308 |